- How To
- Cigar Info
- Site Info
Currently viewing the tag: "health-science"
We highlight issues in how tobacco brand websites address youth access, display warnings, engage consumers and facilitate purchase. Results can help public health educators and practitioners better understand tobacco marketing as a context for designing t
The news comes just days before the price of smokes rises in Australia / Taking up smoking is falling across all age groups except 11 to 15-year-olds / Experts say more anti-smoking adverts need to be targeted at high-risk teens
Air pollution causes a ‘huge’ reduction in intelligence, according to a new study. Earlier this month it was revealed London’s pollution is now so bad it’s equivalent to smoking 251 cigarettes
called on Tuesday for stopping the sale or import of electronic cigarettes and heat-not-burn tobacco devices that companies like Philip Morris International Inc were planning to launch in the country.
The arteries of teenagers who drink alcohol and smoke, even occasionally, are already beginning to stiffen by the age of 17, according to research. The University College London (UCL) study also showed that a combination of high alcohol intake and smokin
A study for environment charity Keep Britain Tidy found 52% of daily smokers polled said they did not see a problem with getting rid of their cigarette butts in this way. Meanwhile, only 53% of those surveyed said they realised ends would finish up in t
Marijuana’s main mind-altering ingredient was detected in nursing mothers’ breast milk in a small study that comes amid evidence that more U.S. women are using pot during pregnancy and afterward. Experts say the ingredient, THC, has chemical properties t
In a statement announcing the new Youth Tobacco Prevention Plan, FDA Commissioner Scott Gottlieb specifically called out JUUL products. JUUL brand e-cigarettes look like a USB flash drive and deliver an aerosol mix of chemicals, nicotine, and flavoring to
nAChRs have consistently presented a promising theoretical use in the treatment of AD; however, trials thus far have been complicated by adverse effects or minimal improvement. This review will provide an update on several pharmacological nAChR agonists t
By examining alpha7 nicotinic receptor biology and recent efforts to target the receptor in clinical trials, it is hoped that investigators will be motivated to explore novel, promising directions focusing on the receptor as a strategy to treat cognitive